Analysis of Crohn's disease-related CARD15 polymorphisms in Spanish patients with idiopathic uveitis

N Rodríguez-Pérez1, A Aguinaga-Barrilero, Marina B Gorroño-Echebarría

  • 1Inmunología, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Disease Markers
|January 26, 2008
PubMed

Insights

Crohn's disease-associated CARD15 gene variations do not appear to increase the risk of idiopathic uveitis in Spanish patients. This study found no significant differences in CARD15 polymorphism frequencies between patients and healthy controls.

Area of Science:

  • Genetics
  • Ophthalmology
  • Gastroenterology

Background:

  • Idiopathic uveitis is an ocular inflammatory condition.
  • CARD15 gene polymorphisms are linked to Crohn's disease, an inflammatory bowel disease.
  • The potential genetic overlap between these conditions is not well understood.

Purpose of the Study:

  • To investigate the frequency of specific Crohn's disease-linked CARD15 polymorphisms (P268S, R702W, G908R, 1007fs) in Spanish patients with idiopathic uveitis.
  • To determine if these CARD15 polymorphisms are associated with an increased risk of developing idiopathic uveitis.

Main Methods:

  • DNA samples were collected from 111 unrelated Spanish patients with idiopathic uveitis and 105 healthy controls.
  • CARD15 polymorphisms (P268S, R702W, G908R) were analyzed using TaqMan Genotyping kits.
  • The 1007fs CARD15 variation was identified through direct DNA sequencing.
  • Two novel intronic polymorphisms near exon 11 were also identified and characterized.

Main Results:

  • No significant difference in the frequencies of the studied CARD15 polymorphisms was observed between the idiopathic uveitis patient group and the healthy control group.
  • Specific gene frequencies for P268S, R702W, G908R, and 1007fs showed no statistically significant increase in patients compared to controls.
  • Two new intronic polymorphisms in phase were identified and registered (GenBank accession #DQ 869189).

Conclusions:

  • The investigated Crohn's disease-linked CARD15 polymorphisms do not appear to be a predisposing factor for idiopathic uveitis in the Spanish population.
  • These findings suggest that CARD15 gene variations associated with Crohn's disease do not play a significant role in the etiology of idiopathic uveitis in this demographic.
  • Further research may be needed to explore other genetic or environmental factors contributing to idiopathic uveitis.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...